Skip to main content
. 2018 Apr 4;91(4):331–335. doi: 10.1016/j.diagmicrobio.2018.03.013

Table 1.

Descriptive statistics of the eligible admissions for periods 1 and 2.

Period 1
(n = 274)
Period 2
(n = 300)
P‐value
Patient characteristics
Age – months (median, range) 19 (0-209) 26 (0-224) <0.01
0–11 months (n, %) 102 (37%) 73 (24%)
12–59 months (n, %) 123 (45%) 150 (50%)
≥60 months (n, %) 49 (18%) 77 (26%)
Female sex (n, %) 110 (40.1) 114 (38.0) 0.60
With a complication (n, %) a 61 (22.3) 39 (13.0) <0.01
With a relevant condition (n, %) b 94 (34.3) 103 (34.3) 0.99
With a respiratory HRG (n, %) c 140 (51.1) 177 (59.0) 0.06
Requiring hospitalization in the High Dependency Unit (HDU) (n, %) 16 (5.8) 25 (8.3) 0.25



Length of Stay
Length of stay – days (median, range) 2 (0-36) 2 (0-116) 0.23
Length of stay on the acute pediatric ward – days (median, range) 2 (0-36) 2 (0-56) 0.91



Drug Utilization and Costs
Admissions with antivirals prescribed (n, %) 15 (5.5) 23 (7.7) 0.29
Admissions with oseltamivir prescribed (n, %) 12 (4.4) 23 (7.7) 0.10
Admissions positive for influenza with oseltamivir prescribed (n, %) 2 (13.3) 8 (40.0) 0.08
Admissions with antibiotics prescribed (n, %) 97 (35.4) 101 (33.7) 0.66
Admissions with immunoglobulins prescribed (n, %) 7 (2.6) 4 (1.3) 0.29
Average total drug cost (£, mean ± SD) 145 ± 470 136 ± 318 0.78



Laboratory Tests Utilization and Costs
Number of laboratory tests per admission (n, mean ± SD) 24 ± 16 23 ± 17 0.41
Number of laboratory tests per admission day (n, mean ± SD) 13 ± 8 12 ± 8 0.11
Average total test cost (£, mean ± SD) 1,251 ± 373 1,219 ± 367 0.31



Reimbursement Charges
Average reimbursement charge for the entire admission (£, mean ± SD) 1,468 ± 2,081 1,444 ± 2,484 0.90
Average reimbursement charge on the acute pediatric ward (£, mean ± SD) 1,355 ± 1,289 1,399 ± 2,421 0.79
a

Complication defined as per the HRG discharge code.

b

ICD-10 codes for relevant conditions (C92, D57, D70, D73, D84, G12, G80, G93, I42, I50, I67, J18, J20, J44, J45, P27, P28, Q02, Q20, Q21, Q22, Q23, Q25, Q31, Q32, Q62, Q90, Z99). Full names can be found in Appendix 3, Supplementary Data.

c

Respiratory HRGs: PA19A, PA14E, PA12Z, PA11Z, PA15A, PA14C, PA19B, PA65A. Full names can be found in Appendix 4, Supplementary Data.